Background:  By 2026 the number of prostate cancer survivors is expected to reach 4.5 million. Although the mortality from prostate cancer has been steadily decreasing, cancer survivors usually have poor outcomes compared to their peers without cancer. The majority of the cancer survivors are over the age of 70 and have progressive medical comorbidities. Identifying [...]